Epidermolysis bullosa pruriginosa with extensive truncal involvement treated with upadacitinib

J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e215-e217. doi: 10.1111/jdv.18487. Epub 2022 Sep 1.

Authors

Nayoung Kim¹, Mihn-Sook Jue¹, Yun Jung Huh¹, Kyung Jeh Sung², Hyunsung Kim³, Jeong Eun Kim¹, Joo Yeon Ko¹

Affiliations

¹ Department of Dermatology, College of Medicine, Hanyang University, Seoul, South Korea.
² Sung Kyung Jeh Skin Clinic, Seoul, South Korea.
³ Department of Pathology, College of Medicine, Hanyang University, Seoul, South Korea.

PMID: 35964304
DOI: 10.1111/jdv.18487

No abstract available

Publication types

Letter

MeSH terms

Collagen Type VII
Epidermolysis Bullosa Dystrophica*
Epidermolysis Bullosa*
Heterocyclic Compounds, 3-Ring
Humans

Substances

upadacitinib
Heterocyclic Compounds, 3-Ring
Collagen Type VII

Supplementary concepts

Epidermolysis Bullosa Pruriginosa